Thus, pharmacological inhibition of CPT1A with ETO or knockdown of CPT1A expression may block fatty acids-induced tumor promoting effects in colon cancer (Supplementary Fig. S6D). This evidence concerns the gene RUNX1T1 and malignant colon neoplasm.